newsfilter
← Latest News
FDA Approved Drugs·

Approval of Recorlev, Nda #214133 (Labeling)

Approval Date: 08/16/2023; Drug Name: Recorlev, Nda #214133; Active Ingredients: LEVOKETOCONAZOLE; Company: Strongbridge; Submission Status: Approval; Submission Classification: Labeling; Application Number: 214133

Company
STRONGBRIDGE
Keywords
STRONGBRIDGE